Rituximab and Liposomal Doxorubicin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Clinical trial NCT00244985 · COMPLETED
Trial details
- NCT number
- NCT00244985
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2008-08-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.